Clinical Trial Update: Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating neoadjuvant chemotherapy with PD-1 inhibitors plus SIB-IMRT for locally advanced rectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer
• Rectal Neoplasms

Snippet

Sponsor: Yong Zhang,MD | Conditions: Rectal Neoplasms | Phase 3 | Status: RECRUITING